Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib

Journal of the European Academy of Dermatology and VenereologyVolume 29, Issue 5 p. 1028-1029 Letter to the Editor Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib R. Coppola, R. Coppola Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorS. Zanframundo, S. Zanframundo Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorM. Verona Rinati, M. Verona Rinati Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorM. Carbotti, M. Carbotti Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorA. Graziano, A. Graziano Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorG. Galati, G. Galati Clinical Medicine-Hepatology, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorL. De Florio, L. De Florio Department of Laboratory Medicine, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorV. Panasiti, Corresponding Author V. Panasiti Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalyCorrespondence: V. Panasiti. E-mail: [email protected]Search for more papers by this author R. Coppola, R. Coppola Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorS. Zanframundo, S. Zanframundo Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorM. Verona Rinati, M. Verona Rinati Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorM. Carbotti, M. Carbotti Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorA. Graziano, A. Graziano Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorG. Galati, G. Galati Clinical Medicine-Hepatology, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorL. De Florio, L. De Florio Department of Laboratory Medicine, Campus Bio-Medico University, Rome, ItalySearch for more papers by this authorV. Panasiti, Corresponding Author V. Panasiti Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, ItalyCorrespondence: V. Panasiti. E-mail: [email protected]Search for more papers by this author First published: 14 March 2014 https://doi.org/10.1111/jdv.12455Citations: 13Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142–151. 2Di Marco V, De Vita F, Koskinas J, Semela D, Toniutto P, Verslype C. Sorafenib: from literature to clinical practice. Ann Oncol 2013; 24(Suppl. 2): ii30–ii37. 3Zhang L, Zhou Q, Ma L, Wu Z, Wang Y. Meta-analysis of dermatological toxicities associated with sorafenib. Clin Exp Dermatol 2011; 36: 344–350. 4Zhao W, Gu YH, Song R, Qu BQ, Xu Q. Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation. Leukemia 2008; 22: 1226–1233. 5Teo M, O'Connor TM, O'Reilly SP, Power DG. Sorafenib-induced tuberculosis reactivation. Onkologie 2012; 35: 514–516. 6Jantzem H, Dupre-Goetghebeur D, Spindler P, Merrer J. Sorafenib-induced multiple eruptive keratoacanthomas. Ann Dermatol Venereol 2009; 136: 894–897. 7Wirth F, Goldani LZ. Epidemiology of Rhodotorula: an emerging pathogen. Interdiscip Perspect Infect Dis 2012; 2012: 465717. 8Tuon FF, Costa SF. Rhodotorula infection. A systematic review of 128 cases from literature. Rev Iberoam Micol 2008; 25: 135–140. 9Means AD, Sisto K, Lichon V, Monaghan D, O'Keefe P, Tung R. Cutaneous Rhodotorula treated with photodynamic therapy. Dermatol Surg 2012; 38(7 Pt 1): 1100–1103. 10Jaeger T, Andres C, Ring J, Anliker MD. Rhodotorula mucilaginosa infection in Li-Fraumeni-like syndrome: a new pathogen in folliculitis. Br J Dermatol 2011; 164: 1120–1122. Citing Literature Volume29, Issue5May 2015Pages 1028-1029 ReferencesRelatedInformation